No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Wells Fargo Maintains Agilon Health(AGL.US) With Buy Rating, Cuts Target Price to $5
Agilon Health Is Maintained at Overweight by Wells Fargo
Express News | Agilon Health, Inc. : Wells Fargo Cuts Target Price to $5 From $6
Agilon Health: Buy Rating Supported by Medicare Advantage Leverage and Margin Recovery
Analysts Have Conflicting Sentiments on These Healthcare Companies: Denali Therapeutics (DNLI) and Agilon Health (AGL)
Take Care Before Jumping Onto Agilon Health, Inc. (NYSE:AGL) Even Though It's 40% Cheaper